期刊
NANO TODAY
卷 8, 期 3, 页码 290-312出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2013.04.007
关键词
Nanomedicine; Nonporous silica nanoparticles; Drug delivery; Gene delivery; Molecular imaging; Nanotoxicity
资金
- NIH [1DP2OD007246-01, 1R21CA152627]
- University of Illinois at Urbana - Champaign from NIH National Cancer Institute Alliance for Nanotechnology in Cancer 'Midwest Cancer Nanotechnology Training Centre' [R25 CA154015A]
Nanomedicine, the use of nanotechnology for biomedical applications, has potential to change the landscape of the diagnosis and therapy of many diseases. In the past several decades, the advancement in nanotechnology and material science has resulted in a large number of organic and inorganic nanomedicine platforms. Silica nanoparticles (NPs), which exhibit many unique properties, offer a promising drug delivery platform to realize the potential of nanomedicine. Mesoporous silica NPs have been extensively reviewed previously. Here we review the current state of the development and application of nonporous silica NPs for drug delivery and molecular imaging. (c) 2013 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据